MAPS (Multidisciplinary Association for
Psychedelic Studies) is a membership-based
organization working to assist researchers
worldwide to design, fund, conduct, obtain
governmental approval for, and report on
psychedelic research in humans. Founded in 1986,
MAPS is an IRS approved 501 (c)(3) non-profit
corporation funded by tax deductible
donations.
MAPS is focused primarily on
assisting scientists to conduct human studies to
generate essential information about the risks and
psychotherapeutic benefits of MDMA, other
psychedelics, and marijuana, with the goal of
eventually gaining government approval for
their medical uses.
Interested parties wishing to
copy any portion of this publication are encouraged
to do so and are kindly requested to credit
MAPS and include our address. The MAPS Bulletin
is produced by a small group of dedicated staff
and volunteers. Your participation, financial or
otherwise, is welcome. |
format or browse below by article. 
